A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM) (NCT07771803)
🩺 Plain-English Summary (8th-Grade Level)
Purpose/Specific Aims The study will determine if there is a reduction in malignant cell burden when patients with relapsed and/or refractory acute myeloid leukemia (AML) or multiple myeloma (MM) consume tea made from the dried leaves of Annona muricata (Soursop). The study goal is to determine the safety and anti-neoplastic efficacy of Annona muricata tea when taken in escalating frequency over a period of 21 days by patients with relapsed/refractory AML or MM for whom there are no standard therapeutic options.
Who can join: Review the eligibility criteria below.
Location: MDA at Cooper University Health Care — Camden, New Jersey
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- MDA at Cooper University Health Care — Camden, New Jersey
📞 Contact the Study Coordinator
Phone: (215) 756-2772
Email: riehmanmurphy-john1@cooperhealth.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in AML (Acute Myeloid Leukemia)
- A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients — Duarte, California
- Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies — Orange, California
- A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML — Grand Rapids, Michigan
Explore by condition: All AML (Acute Myeloid Leukemia) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.